Yüklüyor......
Management of anticoagulation and antiplatelet therapy in patients with primary membranous nephropathy
BACKGROUND: It has been recognized that primary membranous nephropathy (MN) is related to an increased risk for thromboembolic complications. However, the current evidence supporting prophylactic and therapeutic anticoagulation is too weak to better meet the clinical needs of this patient population...
Kaydedildi:
| Yayımlandı: | BMC Nephrol |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6889582/ https://ncbi.nlm.nih.gov/pubmed/31791286 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-019-1637-y |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|